[ad_1]
The Faculty of Medicine of the University of Chile will begin recruit volunteers in two more weeks to test the vaccine developed by the pharmaceutical company Janssen, belonging to the American multinational Johnson & Johnson, which selected Chile as one of the countries to carry out its clinical trials.
To form the group, it will work in coordination with the Cesfam Hill and Esmeralda, located in the commune of Colina, the Exequiel González Cortés Hospital -in which they hope to summon health officials- and the Cesfam Joan Alsina, from San Bernardo.
The academic from the University of Chile, Miguel O’RyanHe stressed that in this last health center “we intend to invite, in addition to the health personnel, volunteers from a food-producing company that is in the area and has more than 4,000 workers.”
Follow-up for two years
The House of Studies hopes to enroll 300 volunteers in Colina; 300 in the hospital of San Miguel and another 400 in San Bernardo. Those who participate must be over 18 years of age and undertake to participate in the project for two years, a period in which the possible duration of immunity and effects of inoculation in patients, as they will be exposed to the virus.
“The goal is to rigorously evaluate how many volunteers are infected between those who received the vaccine and those who received the placebo. If it quickly becomes apparent that there is a significant difference, for example that the vaccine is 70 percent or 80 percent effective, it could be enough to move forward, in the months it takes to demonstrate this level of effectiveness , towards a licensing process for its emergency use in a pandemic period, “O’Ryan explained.
After receiving all the pertinent information about the study and signing the respective consent, participants may receive a random vaccine or placeboIn other words, neither the volunteer nor the health team knows who receives the new product or the harmless substance.
In the following two years after the injection, the university team will be in permanent contact with each volunteer to determine if they develop the disease after the inoculation. Blood samples will also be taken to see the effect of the process on your immune response.
